|
Oct 2
|
Here's Why You Should Add ALNY Stock to Your Portfolio Right Now
|
|
Oct 1
|
Is Alnylam Pharmaceuticals (ALNY) Stock Outpacing Its Medical Peers This Year?
|
|
Oct 1
|
Not Holding Alnylam Pharmaceuticals (ALNY) Hurt Fidelity Growth Strategies Fund’s Performance
|
|
Sep 29
|
Alnylam Highlights New Data From HELIOS-B Study of Vutrisiran for the Treatment of Transthyretin Amyloidosis With Cardiomyopathy at Heart Failure Society of America Annual Scientific Meeting 2024
|
|
Sep 26
|
Alnylam to Webcast TTR Investor Day
|
|
Aug 30
|
Why IBD 50's Alnylam Just Reversed Its 50% Gain — And BridgeBio Surged
|
|
Aug 30
|
Alnylam Stock Falls on Positive but Disappointing Study Results for Heart Drug
|
|
Aug 30
|
ESC 2024: Amvuttra data signals positive prospects in cardiomyopathy for Alnylam
|
|
Aug 30
|
Alnylam Pharmaceuticals Reports Substantial Results of Vutrisiran's Phase 3 Study as Heart Disease Therapy
|
|
Aug 30
|
Alnylam Presents Detailed Results from the Positive HELIOS-B Phase 3 Study of Vutrisiran▼ in Patients with ATTR Amyloidosis with Cardiomyopathy at the European Society of Cardiology Congress
|
|
Aug 30
|
Full study data back Alnylam heart drug’s benefit, but leave doctors with tough choices
|
|
Aug 28
|
Alnylam to Webcast Presentations at Upcoming September Investor Conferences
|
|
Jul 29
|
Analysts Estimate CRISPR Therapeutics AG (CRSP) to Report a Decline in Earnings: What to Look Out for
|
|
Jul 25
|
Alnylam Pharmaceuticals (ALNY) May Report Negative Earnings: Know the Trend Ahead of Next Week's Release
|
|
Jul 18
|
Alnylam to Webcast Conference Call Discussing Second Quarter 2024 Financial Results
|
|
Jun 27
|
Biotech Stock Roundup: ALNY Up on Study Success, ALIM on Merger News & Other Updates
|
|
Jun 25
|
Alnylam (ALNY) Soars as Heart Disease Drug Study Meets Goals
|
|
Jun 25
|
Top Three US Stocks Estimated Below Intrinsic Value In June 2024
|
|
Jun 24
|
Alnylam Skyrockets After Hitting A 'Best-Case Scenario' For Heart Drug
|
|
Jun 24
|
Sector Update: Health Care Stocks Rise in Late Afternoon Trading
|